OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea
· Delayed Price · Currency is KRW 41,050
+2,750 (7.18%)
Apr 1, 2025, 3:30 PM KST
OliX Pharmaceuticals Revenue
In the year 2024, OliX Pharmaceuticals had annual revenue of 5.68B KRW, down -66.73%. OliX Pharmaceuticals had revenue of 45.21M in the quarter ending December 31, 2024, a decrease of -99.57%.
Revenue
5.68B
Revenue Growth
-66.73%
P/S Ratio
121.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
764.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |